Breast cancer screening: Benefit or harm?

JAMA - Journal of the American Medical Association

Volumn 315, Issue 13, 2016, Pages 1402-

  Jorgensen, Karsten Juhl ^a   Gotzsche, Peter C ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; EVIDENCE BASED MEDICINE; HUMAN; LETTER; MENTAL STRESS; POPULATION DISTRIBUTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; BREAST TUMOR; EARLY CANCER DIAGNOSIS; ECHOGRAPHY; FEMALE; MAMMOGRAPHY; STANDARDS;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY;

EID: 84962606519     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.19126     Document Type: Letter

References (5)

1. Myers ER, Moorman P, Gierisch JM, et al. Benefits and harms of breast cancer screening: a systematic review. JAMA. 2015;314(15):1615-1634.
2. Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013;6:CD001877.
3. Jüni P, Zwahlen M. It is time to initiate another breast cancer screening trial. Ann Intern Med. 2014;160(12):864-866.
4. Schünemann H, Brozek J, Guyatt G, Oxman A. GRADE handbook. http://gdt .guidelinedevelopment.org/central-prod/-design/client/handbook/handbook .html. Accessed October 29, 2015.
5. Dowsett M, Forbes JF, Bradley R, et al. Aromatase inhibitors vs tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet. 2015;386(10001):1341-1352.